July 19th 2024
Pluri’s newly launched CDMO business will manufacture two novel cell therapy product candidates for Kadimastem.
Human Vaccines Project Creates Research Program to Develop Universal Influenza Vaccines
November 3rd 2017The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.
Single-Use Bioreactors for the Rapid Production of Preclinical and Clinical Biopharmaceuticals
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.